drugset / Trial / NCT03125694
Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea
RandomizedParallel-groupOpen-labelTreatment
Summary
This study has been designed to investigate the comparative effects of sitagliptin vs. pioglitazone as add-on treatments in patients with type 2 diabetes who were uncontrolled on the full-dose of metformin and sulfonylurea
Timeline
- Start
- 2015-02-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |